← Insider buys
CHRS

Coherus Oncology, Inc. · Healthcare

Chief Scientific Officer Vladimir Vexler sold $1.2M of Coherus Oncology, Inc.

Sold$1,221,150
$18.19Price
67,138Shares
−65%Stake

What CHRS did after the filing

Prices for CHRS after this filing aren't in yet.

Traded Wed, Dec 9. Filed Fri, Dec 11, 11:39 AM ET, during the session. Not investment advice.